<DOC>
	<DOCNO>NCT00799552</DOCNO>
	<brief_summary>The purpose study compare safety efficacy RX-10045 placebo treatment sign symptom dry eye .</brief_summary>
	<brief_title>Safety Efficacy Study RX-10045 Signs Symptoms Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Signs Symptoms</mesh_term>
	<criteria>Be least 18 year age ; Have provide write informed consent ; Have history dry eye least 6 month prior enrollment ; Have history use desire use eye drop dry eye symptom within past 6 month ; Demonstrate response expose CAE . Have ongoing ocular infection , active ocular inflammation Have wear contact lenses within 72 hour Visit 1 anticipate use contact lenses study ; Have contact lensinduced dry eye ; Have previously laser situ keratomileusis ( LASIK ) surgery ; Be use anticipate use temporary punctual plug study ; Have best correct visual acuity &gt; +0.7 eye ; Be woman pregnant , nurse planning pregnancy ; Have know allergy and/or sensitivity test article component ; Be currently use medication know cause ocular drying use stable dose regimen least 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Keratoconjunctivitis Sicca</keyword>
	<keyword>Dry eye</keyword>
	<keyword>Resolvin</keyword>
</DOC>